Resumen
Abstract: – Artificial intelligence (AI) has been increasingly integrated into medical publishing, hopefully improving efficiency and accuracy, but serious concerns persist regarding ethical implications, authorship attribution, and content reliability. We aimed at understanding the perspectives of editors of medical journals on AI. A structured online questionnaire was developed and distributed to editors-in-chief of medical journals worldwide. The survey comprised 27 concise questions exploring demographics, journal practices, and perspectives on AI in editorial workflows. Quantitative data were analyzed using descriptive statistics to summarize usage patterns, perceived benefits, risks, and future expectations. A total of 59 editors-in-chief completed the survey (response rate: 19%), with replies suggesting substantial variability in beliefs and attitudes toward AI for publication in medical journals. Artificial intelligence tools were already in use by 49% of journals, mainly for plagiarism detection (76%) and data verification (35%). Only 9% of responders reported that journals used AI for both scientific and linguistic review. Time savings (79%) and cost reduction (43%) were the most commonly cited benefits, and concerns included potential bias (71%) and lack of accountability (60%). Overall, 81% of responders anticipated a major role for AI in publishing within 10 years. Exploratory analyses suggested several potential associations between replies and respondent or journal features, requiring further validation in future surveys. In conclusion, this survey on attitudes toward AI in publication in medical journals suggests that editors-in-chief are cautiously adopting AI in their editorial workflow, supporting its operational use while explicitly calling for clear guidance to address ethical and regulatory concerns.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 374-383 |
| Número de páginas | 10 |
| Publicación | Journal of Cardiovascular Pharmacology |
| Volumen | 86 |
| N.º | 4 |
| DOI | |
| Estado | Published - nov 25 2025 |
Nota bibliográfica
Publisher Copyright:© 2025
Financiación
Research leading to this work has received funding from the European Union—NextGenerationEU, through the Italian Ministry of University and Research, under PNRR - M4C2-I1.3 Project PE_00000019 “HEAL ITALIA” to Giuseppe Biondi-Zoccai CUP B53C22004000006 Sapienza University of Rome. The views and opinions expressed are those of the authors only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the European Commission can be held responsible for them. George W. Booz was supported in part by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM121334. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
| Financiadores | Número del financiador |
|---|---|
| National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical Sciences | |
| Università degli Studi di Roma Unitelma Sapienza | |
| European Commission | |
| Ministero dell’Istruzione, dell’Università e della Ricerca | PNRR - M4C2-I1.3, PE_00000019 |
| National Institutes of Health (NIH) | P20GM121334 |
ASJC Scopus subject areas
- Pharmacology
- Cardiology and Cardiovascular Medicine
Huella
Profundice en los temas de investigación de 'Perspectives on Artificial Intelligence in Medical Publishing: A Survey of Medical Journal Editors'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver